Breast Screening Guideline Debates & CEM Advances

Ongoing debate between biennial vs annual MRI screening, with landmark NICE criteria study showing 95% of young women missed. New: Australia's BreastScreen moving to risk-stratified screening, piloting CEM and AI. New: Abbreviated breast MRI for NAC response shows comparable performance to full protocol, supporting workflow. CEM continues to gain traction as cost-effective alternative in LMICs. New data on family history modifying BRCA risk estimates supports personalized screening.